FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Filippo Montemurro

Research Profile

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Genes, erbB-2

Procedures

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Daniele Recupero; Alberto Righi; Mauro Risio; Nicoletta Biglia; Paola Cassoni; Isabella Castellano; Lorenzo Daniele; Caterina Marchiò; Luca Molinaro; Filippo Montemurro; Piero Sismondi; Giuseppe Viale; Anna Sapino
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
Filippo Montemurro; Valentina Rossi; Ivana Sarotto; Giorgio Valabrega; Massimo Aglietta; Marco Gatti; Franziska Kubatzki; Furio Maggiorotto; Alessandra Magistris; Francesco Marocco; Riccardo Ponzone
Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
Filippo Montemurro; Valentina Rossi; Giorgio Valabrega; Elena Geuna; Rossella Martinello; Andrea Milani; Massimo Aglietta
Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Filippo Montemurro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniele Recupero; Alberto Righi; Mauro Risio; Nicoletta Biglia; Paola Cassoni; Isabella Castellano; Lorenzo Daniele; Caterina Marchiò; Luca Molinaro; Filippo Montemurro; Piero Sismondi; Giuseppe Viale; Anna Sapino
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
The Journal of pathology 2013;229(3):390-9.
2012: Filippo Montemurro; Valentina Rossi; Ivana Sarotto; Giorgio Valabrega; Massimo Aglietta; Marco Gatti; Franziska Kubatzki; Furio Maggiorotto; Alessandra Magistris; Francesco Marocco; Riccardo Ponzone
Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
Annals of surgical oncology 2012;19(12):3755-61.
2012: Filippo Montemurro; Valentina Rossi; Giorgio Valabrega; Elena Geuna; Rossella Martinello; Andrea Milani; Massimo Aglietta
Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer.
Expert opinion on pharmacotherapy 2012;13(15):2143-56.
2012: Marta D'Alonzo; Franziska Kubatzki; Furio Maggiorotto; Laura Martincich; Filippo Montemurro; Alberto Pisacane; Giovanni De Rosa; Piero Sismondi; Nicoletta Biglia; Riccardo Ponzone
Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2012;48(15):2311-8.
2012: Laura Martincich; Massimo Aglietta; Ilaria Bertotto; Veronica Deantoni; Franziska Kubatzki; Michele Liotti; Riccardo Ponzone; Stefania Redana; Daniele Regge; Valentina Rossi; Ivana Sarotto; Filippo Montemurro
Correlations between diffusion-weighted imaging and breast cancer biomarkers.
European radiology 2012;22(7):1519-28.
2012: S Gori; Giulio Metro; Filippo Montemurro; R R Silva; Simon Spazzapan; L Stocchi; E Torrisi; G Bisagni; Matteo Clavarezza; F Cognetti; A Fabi; A Ferzi; J Foglietta; Teresa Gamucci; D Crivellari
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1436-41.
2012: GIOVANNI CARLO ANSELMETTI; Antonio Capaldi; Fabrizio Carnevale Schianca; Gabriele Chiara; Felicino Debernardi; Giovanni Grignani; Joshua Hirsch; Gabriella Iussich; Antonio Manca; Filippo Montemurro; Delia Rota Scalabrini; Elena Sardo; Daniele Regge
Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patients.
Cardiovascular and interventional radiology 2012;35(1):139-45.
2012: Valentina Rossi; Ivana Sarotto; Nicoletta Tomasi; Giorgio Valabrega; Massimo Aglietta; Paola Berchialla; Franziska Kubatzki; Furio Maggiorotto; Rossella Martinello; Riccardo Ponzone; Stefania Redana; Filippo Montemurro
Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.
The oncologist 2012;17(11):1418-25.
2012: GIOVANNI CARLO ANSELMETTI; Massimo Battistella; Gabriele Chiara; Antonio Manca; Stefano Marcia; Salvatore Masala; Filippo Montemurro; Maurizio Savojardo; Sean Tutton; Daniele Regge
Vertebroplasty using transoral approach in painful malignant involvement of the second cervical vertebra (C2): a single-institution series of 25 patients.
Pain physician 2012;15(1):35-42.
2011: Giorgio Valabrega; Gianluca Zaccarello; Carla Pecchioni; Caterina Peraldo-Neia; Annalisa Petrelli; Anna Sapino; Massimo Aglietta; Sonia Capellero; Giuliana Cavalloni; Loretta Gammaitoni; Silvia Giordano; Giorgia Migliardi; Andrea Milani; Aldo Moggio; Filippo Montemurro
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Breast cancer research and treatment 2011;130(1):29-40.
2011: Caterina Peraldo-Neia; Giorgia Migliardi; Maurizia Mello-Grand; Filippo Montemurro; Raffaella Segir; Ymera Pignochino; Giuliana Cavalloni; Bruno Torchio; Luciano Mosso; Giovanna Chiorino; Massimo Aglietta
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
BMC cancer 2011;11():31.
2010: Stefania Redana; Michela Donadio; Franco Nolè; Maria Elena Jacomuzzi; Alessandra Beano; Rossella Martinello; Anna Sapino; Giuseppe Viale; Massimo Aglietta; Filippo Montemurro
Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.
BMC cancer 2010;10():28.
2007: Anna Sapino; Filippo Montemurro; Caterina Marchiò; Giuseppe Viale; Janina Kulka; Michela Donadio; Alberto Bottini; G Botti; A P dei Tos; Alessandra Bersiga; S Di Palma; M Truini; G Sanna; Massimo Aglietta; Gianni Bussolati
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1963-8.
2007: Filippo Montemurro; Massimo Aglietta
Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer?
Nature clinical practice. Oncology 2007;4(7):398-9.
2007: Filippo Montemurro; Stefania Redana; Giorgio Valabrega; Massimo Aglietta
Recent advances in the medical management of breast cancer: highlights from the 29th San Antonio Breast Cancer Conference San Antonio, TX, USA, 14-17 December 2007.
Expert opinion on pharmacotherapy 2007;8(8):1179-88.
2007: Giorgio Valabrega; Filippo Montemurro; Massimo Aglietta
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(6):977-84.
2007: Filippo Montemurro; Laura Martincich; Ivana Sarotto; Ilaria Bertotto; Riccardo Ponzone; Lisa Cellini; Stefania Redana; Piero Sismondi; Massimo Aglietta; Daniele Regge
Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer.
European radiology 2007;17(6):1490-7.
2007: Filippo Montemurro; Giorgio Valabrega; Massimo Aglietta
Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity.
Expert opinion on biological therapy 2007;7(2):257-68.
2007: Cinzia Ortega; Filippo Montemurro; Roberto Faggiuolo; Roberto Vormola; Daniela Nanni; Franco Goia; Marco Ottavio Gilardino; Massimo Aglietta
Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.
Acta oncologica (Stockholm, Sweden) 2007;46(5):664-8.
2006: Riccardo Ponzone; Filippo Montemurro; Furio Maggiorotto; Claudio Robba; Dario Gregori; Maria Elena Jacomuzzi; Franziska Kubatzki; Davide Marenco; Annelise Dominguez; Nicoletta Biglia; Piero Sismondi
Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1631-6.
2006: Filippo Montemurro; Giorgio Valabrega; Massimo Aglietta
Trastuzumab treatment in breast cancer.
The New England journal of medicine 2006;354(20):2186; author reply 2186.
2006: Filippo Montemurro; Michela Donadio; Matteo Clavarezza; Stefania Redana; Maria Elena Jacomuzzi; Giorgio Valabrega; Saverio Danese; Guido Vietti-Ramus; Antonio Durando; Marco Venturini; Massimo Aglietta
Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.
The oncologist 2006;11(4):318-24.
2006: Filippo Montemurro; Marco Gatti; Stefania Redana; Maria Elena Jacomuzzi; Daniela Nanni; Antonio Durando; M Popolo; Riccardo Ponzone; A Rossi; V Albieri; Giorgio Valabrega; Piero Sismondi; P Gabriele; Massimo Aglietta
Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer.
Journal of chemotherapy (Florence, Italy) 2006;18(1):90-7.
2006: Cinzia Ortega; Roberto Faggiuolo; Roberto Vormola; Filippo Montemurro; Daniela Nanni; F Goia; Massimo Aglietta
Jaw complications in breast and prostate cancer patients treated with zoledronic acid.
Acta oncologica (Stockholm, Sweden) 2006;45(2):216-7.
2005: Filippo Montemurro; Giorgio Valabrega; Lucia Garetto; Sandra Aliberti; Giovanni Grignani; Cinzia Ortega; Francesco Leone; Riccardo Ponzone; Massimo Aglietta
The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
Expert opinion on pharmacotherapy 2005;6(16):2907-21.
2005: Filippo Montemurro; Stefania Redana; Giorgio Valabrega; Massimo Aglietta
Controversies in breast cancer: adjuvant and neoadjuvant therapy.
Expert opinion on pharmacotherapy 2005;6(7):1055-72.
2005: Filippo Montemurro; Laura Martincich; Giovanni De Rosa; Stefano Cirillo; Vincenzo Marra; Nicoletta Biglia; Marco Gatti; Piero Sismondi; Massimo Aglietta; Daniele Regge
Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer.
European radiology 2005;15(6):1224-33.
2005: Giorgio Valabrega; Filippo Montemurro; Ivana Sarotto; Annalisa Petrelli; Patrizia Rubini; Carlo Tacchetti; Massimo Aglietta; paolo comoglio; silvia giordano
TGFalpha expression impairs Trastuzumab-induced HER2 downregulation.
Oncogene 2005;24(18):3002-10.
2005: Filippo Montemurro; Roberto Faggiuolo; Stefania Redana; Michela Donadio; Monica Minischetti; Antonio Durando; Guido Vietti-Ramus; Roberta Buosi; Massimo Aglietta
Continuation of trastuzumab beyond disease progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2866-8; discussion 2868-9.
2005: Gianni Bussolati; Filippo Montemurro; Luisella Righi; Michela Donadio; Massimo Aglietta; Anna Sapino
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer.
British journal of cancer 2005;92(7):1261-7.
2005: Filippo Montemurro; Massimo Aglietta
Incorporating trastuzumab into the neoadjuvant treatment of HER2-overexpressing breast cancer.
Clinical breast cancer 2005;6(1):77-80.
2005: Mauro Risio; Laura Casorzo; Stefania Redana; Filippo Montemurro
HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment.
Oncology reports 2005;13(2):305-9.
2004: Filippo Montemurro; Ivana Sarotto; Laura Casorzo; Alberto Pisacane; Massimo Aglietta; Giovanni De Rosa
HER2 and central nervous system metastasis in patients with breast cancer.
Clinical breast cancer 2004;5(3):232-4.
2004: Filippo Montemurro; F Russo; Laura Martincich; Stefano Cirillo; Marco Gatti; Massimo Aglietta; Daniele Regge
Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
Acta radiologica (Stockholm, Sweden : 1987) 2004;45(1):71-4.
2004: Filippo Montemurro; Gabriella Choa; Roberto Faggiuolo; Michela Donadio; Monica Minischetti; Antonio Durando; Antonio Capaldi; Guido Vietti-Ramus; Oscar Alabiso; Massimo Aglietta
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer.
Oncology 2004;66(1):38-45.
2004: Laura Martincich; Filippo Montemurro; Giovanni De Rosa; Vincenzo Marra; Riccardo Ponzone; Stefano Cirillo; Marco Gatti; Nicoletta Biglia; Ivana Sarotto; Piero Sismondi; Daniele Regge; Massimo Aglietta
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.
Breast cancer research and treatment 2004;83(1):67-76.
2004: Filippo Montemurro; Giorgio Valabrega; Massimo Aglietta
Trastuzumab-based combination therapy for breast cancer.
Expert opinion on pharmacotherapy 2004;5(1):81-96.
2003: Alberto Ballestrero; Filippo Montemurro; Roberta Gonella; Antonio Capaldi; Marco Danova; Daniele Friedman; Maria Puglisi; Massimo Aglietta; Franco Patrone
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.
Breast cancer research and treatment 2003;82(3):185-90.
2003: Laura Martincich; Filippo Montemurro; Stefano Cirillo; Vincenzo Marra; Giovanni De Rosa; Riccardo Ponzone; Massimo Aglietta; Daniele Regge
Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
La Radiologia medica 2003;106(1-2):51-8.
2003: Filippo Montemurro; Gabriela Rondón; Mark F Munsell; Terry L Smith; Michele L Donato; James L Gajewski; Zia Rahman; Aman U Buzdar; Richard E Champlin; Naoto T Ueno
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(5):330-40.
2003: Filippo Montemurro; Gabriella Choa; Roberto Faggiuolo; Elisa Sperti; Antonio Capaldi; Michela Donadio; Monica Minischetti; Attilio Salomone; Guido Vietti-Ramus; Oscar Alabiso; Massimo Aglietta
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study.
American journal of clinical oncology 2003;26(1):95-7.
2002: Filippo Montemurro; Gabriela Rondón; Naoto T Ueno; M Munsell; James L Gajewski; Richard E Champlin
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
Bone marrow transplantation 2002;29(10):861-6.
2001: Y S Kim; Sergej Konoplev; Filippo Montemurro; Emma Hoy; Terry L Smith; Gabriela Rondón; Richard E Champlin; Aysegul A Sahin; Naoto T Ueno
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4008-12.
2000: Filippo Montemurro; Naoto T Ueno; Gabriela Rondón; Massimo Aglietta; Richard E Champlin
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends.
Clinical breast cancer 2000;1(3):197-209; discussion 210.
1997: Mauro Papotti; P Riella; Filippo Montemurro; F Pietribiasi; Gianni Bussolati
Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid.
Histopathology 1997;31(6):525-33.
1997: GC Abbona; Mauro Papotti; Filippo Montemurro; Laura Viberti; Anna Sapino; Gianni Bussolati
[Standardized pathological reporting for tumors].
Pathologica 1997;89(5):546-65.
1997: Filippo Montemurro; Margherita Gallicchio; Massimo Aglietta
[Prevention and treatment of febrile neutropenia].
Tumori 1997;83(2 Suppl):S15-9.